Scientists cautiously suggest GLP-1s are safe to use around pregnancy

A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of Obstetrics and Gynaecology, the study presents the largest ever systematic review of more than 49,000 pregnancies over a period of 20 years that were exposed to GLP-1 receptor agonists.